Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

200
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
200
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

570
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
570
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

105
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
105
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

220
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
220
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

413
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
413
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

106
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
106

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Lactiplantibacillus plantarum</i> <sup>WJL</sup> ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein diet.

Gut microbes·2026
Same author

Kidney dysfunction regulates gut transporters.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Supplementation with <i>Enterococcus lactis</i> (SF68) and its association with biochemical parameters and inflammatory biomarkers related to renal impairment in dogs with chronic kidney disease.

The veterinary quarterly·2026
Same author

Kidney Function Modulates Gut Microbial Metabolism.

Toxins·2026
Same author

Corrigendum to "Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease." [Biomed. Pharmacother. 197 (2026), 119131].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Related Experiment Video

Updated: Oct 29, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.2K

Uremic Toxins and Cardiovascular System.

Sophie Valkenburg1, Griet Glorieux1, Raymond Vanholder1

  • 1Nephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Corneel Heymanslaan 10, Gent 9000, Belgium.

Cardiology Clinics
|July 12, 2021
PubMed
Summary

Chronic kidney disease (CKD) causes uremic toxins to build up, leading to cardiovascular damage through various mechanisms. Treatments targeting toxin production, like those from gut bacteria, are being explored.

Keywords:
Cardiorenal syndromeCardiovascular damageKidney damagePathophysiologyUremic toxins

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.5K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.9K

Related Experiment Videos

Last Updated: Oct 29, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.2K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.5K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.9K

Area of Science:

  • Nephrology
  • Cardiology
  • Toxicology

Background:

  • Chronic kidney disease (CKD) impairs the kidneys' ability to excrete metabolic waste products.
  • This leads to the accumulation of uremic toxins, which disrupt biological functions and can cause cardiovascular damage.
  • Several uremic toxins are implicated in cardiovascular complications associated with CKD.

Purpose of the Study:

  • To review the primary cardiotoxic mechanisms driven by uremic toxin retention in CKD.
  • To identify the key uremic compounds responsible for these cardiotoxic effects.
  • To discuss potential therapeutic strategies, including modulating intestinal microbiota.

Main Methods:

  • Literature review of studies on chronic kidney disease, uremic toxins, and cardiovascular disease.
  • Analysis of established cardiotoxic mechanisms linked to uremic toxin accumulation.
  • Examination of therapeutic interventions targeting uremic toxin generation.

Main Results:

  • Uremic toxin retention contributes to cardiotoxicity via endothelial dysfunction, vascular smooth muscle cell alterations, inflammation, mineral bone disorder, insulin resistance, and increased thrombogenicity.
  • Specific retention compounds are identified as major contributors to these detrimental effects.
  • Therapeutic strategies focusing on reducing solute generation, particularly from intestinal microbiota, show promise.

Conclusions:

  • Uremic toxins play a critical role in the cardiovascular complications of CKD.
  • Understanding the specific mechanisms and responsible compounds is essential for targeted therapies.
  • Interventions aimed at reducing the burden of uremic toxins, including those influenced by gut microbiota, represent a viable therapeutic avenue.